Ekso Bionics Holdings Inc reports results for the quarter ended in December - Earnings Summary

Chronoscale

05/03/2024 23:29

* Ekso Bionics Holdings Inc  EKSO.OQ  reported a quarterly
adjusted loss of 22 cents​​ per share for the quarter ended in
December.  The lone analyst forecast for the quarter was for a
loss of 11 cents per share. 
    * Revenue rose 36.5% to $4.85 million from a year ago;
analysts
expected $4.77 million. 
    * Ekso Bionics Holdings Inc's reported EPS for the quarter
was a
loss of 22 cents​.
    * The company reported a quarterly loss of $3.21 million.
    * Ekso Bionics Holdings Inc shares had fallen by 16.0% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 66.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $9.25 

This summary was machine generated from LSEG data March 5 at
11:28 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.11          -0.22          Missed
 Sep. 30 2023      -0.31          -0.24          Beat
 Jun. 30 2023      -0.28          -0.31          Missed
 Mar. 31 2023      -0.31          -0.33          Missed